As a proof of principle, we focused on BRAF p.V600E (c.T1799A; dbSNP: rs113488022), a gain-of-function hotspot mutation at PAM+1 commonly found in but not unique to melanoma, thyroid cancer, and colorectal cancer (Figure 1E).13 This evidence concerns the gene BRAF and thyroid gland carcinoma.